AILERON THERAPEUTICS INC·4

Aug 14, 7:38 PM ET

LONGENECKER JOHN P PHD 4

4 · AILERON THERAPEUTICS INC · Filed Aug 14, 2018

Insider Transaction Report

Form 4
Period: 2018-08-10
LONGENECKER JOHN P PHD
President and CEO
Transactions
  • Purchase

    Common Stock

    2018-08-10$2.45/sh+10,000$24,50010,000 total
Footnotes (1)
  • [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40 to $2.48, inclusive. The reporting person undertakes to provide to Aileron Therapeutics, Inc., any security holder of Aileron Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION